About this release

This annual release by Public Health Scotland (PHS) presents data on the uptake of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP), HIV testing, HIV diagnoses, access to specialist HIV care and uptake of anti-retroviral therapy (ART) in Scotland.

Main points

  • Scotland is making good progress towards HIV transmission elimination targets. At 31 December 2024, an estimated 6,467 people were living with HIV in Scotland. Of the 94% (6,079) diagnosed, 91% (5,520/6,079) received ART between 1 July 2023 and 31 December 2024, and 95% (5,260/5,520) had a suppressed viral load (more information is available on the Terrence Higgins Trust website).
Image caption Annual number of HIV diagnoses by mode of acquisition, Scotland, 2015-2024
  1. All modes of acquisition include diagnoses currently under investigation.
  2. All modes of acquisition include those whose mode of acquisition is recorded as other or not known.
  • From 1 January to 31 December 2024, 2,472 individuals accessed HIV PrEP for the first time, averaging 206 per month. This is the second highest monthly average, since the HIV PrEP programme started in July 2017, exceeded only by 216 per month in the period 1 January to 31 December 2023.
  • Access to services during the COVID-19 pandemic impacted HIV testing levels; however, there is evidence of testing recovery with initiatives being implemented in key settings including sexual health services, drug services and prisons.
  • In 2024, 375 HIV diagnoses were recorded in Scotland, the majority (67%, 250/375) of which were previously known diagnoses recorded for the first time in Scotland and were largely attributed to heterosexual sexual intercourse and acquisition outwith Scotland.
  • Of the 375 HIV reports in 2024, 125 were first time diagnoses. Since 2017, the annual number of first ever diagnoses recorded has nearly halved, decreasing from 225 to 125.
  • Of the 125 first time diagnoses, 19% were thought to be transmissions which had occurred in Scotland; this represents a decline compared to 2023 and progress towards achieving Scotland's goal of zero HV transmissions within Scotland by 2030.

Background

Human immunodeficiency virus (HIV) attacks the immune system, causing a chronic, lifelong infection which can be managed successfully by antiretroviral therapy. HIV can be transmitted through condomless vaginal and anal sex, sharing needles, syringes or other injecting equipment and transmission from mother to baby during pregnancy, birth or breastfeeding. Untreated HIV infection progresses to advanced HIV disease or acquired immune deficiency syndrome (AIDS). People diagnosed with HIV and on ART are able to live long, healthy lives. HIV PrEP is highly effective for preventing sexual acquisition of HIV.

Further information

The next release of this publication will be Autumn 2026.

General enquiries

If you have an enquiry relating to this publication, please contact Beth Cullen at phs.bbvsti@phs.scot.

Media enquiries

If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.

Requesting other formats and reporting issues

If you require publications or documents in other formats, please email phs.otherformats@phs.scot.

To report any issues with a publication, please email phs.generalpublications@phs.scot.

Older versions of this publication

Versions of this publication released before 16 March 2020 may be found on the Data and Intelligence, Health Protection Scotland or Improving Health websites.

Last updated: 23 September 2025
Was this page helpful?